Tag: Pharmaceutical industry
Understanding the Implications of Trump’s Medicare Drug Price Negotiations
President Donald Trump has set his sights on Medicare drug price negotiations. While he is not likely to dismantle the negotiation process entirely, he is expected to make significant changes that could impact the...
Biotech Startups Challenging Eli Lilly and Novo Nordisk dominance
In the fast-paced world of pharmaceuticals, the landscape has seen a notable shift between 2021 and 2023. During this period, two key sectors within the drugmaking industry experienced contrasting fortunes. On one hand, the...
FDA Approves Vertex’s Non-Opioid Painkiller: Breakthrough Pain Medicine
The Food and Drug Administration recently made a groundbreaking decision to approve Vertex Pharmaceuticals' non-opioid painkiller pill, known as Journavx. This approval marks a significant milestone, as Vertex becomes the first drugmaker in decades...
Eli Lilly Stock Plummets Due to Reduced Revenue Forecast for Weight Loss Drug
Eli Lilly Stock Plummets Amid Reduced Revenue Forecast for Weight Loss DrugEli Lilly & Co., a prominent pharmaceutical company, experienced a significant drop in its stock value recently due to a revised...
Upcoming Approval Expected for Eli Lilly’s New Weight Loss Pill in 2023
**Eli Lilly's Revolutionary Weight Loss Pill Set for Approval in 2023**Eli Lilly, a pharmaceutical giant, is on the brink of introducing a groundbreaking weight loss pill that could revolutionize the industry. CEO David Ricks...
FDA Announces End of Zepbound Shortage: Impact on Compounding Pharmacies and Patients
Impact of FDA Decision on Compounded Tirzepatide Availability
The Food and Drug Administration's recent announcement of the end of the tirzepatide shortage has sent shockwaves through the world of compounding pharmacies and patients who rely...
